Correlation Between Transgene and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Transgene and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transgene and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transgene SA and Lumos Pharma, you can compare the effects of market volatilities on Transgene and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transgene with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transgene and Lumos Pharma.
Diversification Opportunities for Transgene and Lumos Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Transgene and Lumos is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Transgene SA and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Transgene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transgene SA are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Transgene i.e., Transgene and Lumos Pharma go up and down completely randomly.
Pair Corralation between Transgene and Lumos Pharma
If you would invest 159.00 in Transgene SA on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Transgene SA or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Transgene SA vs. Lumos Pharma
Performance |
| Timeline |
| Transgene SA |
| Lumos Pharma |
Transgene and Lumos Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transgene and Lumos Pharma
The main advantage of trading using opposite Transgene and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transgene position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.| Transgene vs. Here Media | Transgene vs. Employers Holdings | Transgene vs. Stagwell | Transgene vs. Sun Life Financial |
| Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Eliem Therapeutics | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Correlations Find global opportunities by holding instruments from different markets |